GL1X · GenesisL1 explorer

Research workbench

HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P212121

Analyse HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3S53
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
Q7SSI0
Ligands
017, IOD, PO4
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein994% helix, 54% strandQ7SSI0

Ligands and binding sites

  • 017 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate · ligand · 2 copies · chains A, B
  • IOD · Iodide ion · ion · 10 copies · chains A, B
  • PO4 · Phosphate ion · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13650.710.8335017

Interfaces

1 interface between chains.

  • A–B · 1872 Ų buried · 35 hydrogen bonds · protein-protein

Compared structures

  • 3S53 · HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.